← Evidence map

ArticleVaccine2025

Assessing the risks of current COVID-19 challenge trials systematically.

Nir Eyal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40016019